BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 11149623)

  • 1. Toward cell-based therapy of type I diabetes.
    Kabelitz D; Geissler EK; Soria B; Schroeder IS; Fändrich F; Chatenoud L
    Trends Immunol; 2008 Feb; 29(2):68-74. PubMed ID: 18182324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of in vitro-generated, stem cell-derived islets to cure type 1 diabetes: how close are we?
    Peck AB; Cornelius JG; Chaudhari M; Shatz D; Ramiya VK
    Ann N Y Acad Sci; 2002 Apr; 958():59-68. PubMed ID: 12021084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of adipose tissue derived stem cells differentiated into insulin producing cells in the treatment of type I diabetes mellitus.
    Amer MG; Embaby AS; Karam RA; Amer MG
    Gene; 2018 May; 654():87-94. PubMed ID: 29452233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current perspectives of biotechnological replacement of insulin secreting cells.
    Pfeiffer AF
    Exp Clin Endocrinol Diabetes; 2000; 108(8):494-7. PubMed ID: 11149623
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment diabetes by transplantation of insulin secreting cells. Part I].
    Pokrywczyńska M; Drewa T; Włodarczyk Z; Dufrane D
    Pol Merkur Lekarski; 2006 May; 20(119):615-8. PubMed ID: 16875175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Production of insulin secreting cells from stem cells].
    Martín F; Jones J; Vaca P; Berna G; Soria B
    Journ Annu Diabetol Hotel Dieu; 2003; ():23-30. PubMed ID: 12868298
    [No Abstract]   [Full Text] [Related]  

  • 7. Differentiation of stem cells into insulin-producing cells: current status and challenges.
    Pokrywczynska M; Krzyzanowska S; Jundzill A; Adamowicz J; Drewa T
    Arch Immunol Ther Exp (Warsz); 2013 Apr; 61(2):149-58. PubMed ID: 23283518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Islet cell transplantation: a step toward curing diabetes?].
    Philips JC; Radermecker R; Scheen AJ
    Rev Med Liege; 2003 Feb; 58(2):83-7. PubMed ID: 12693308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cells and regenerative medicine for the treatment of type 1 diabetes: the challenges lying ahead.
    Lechner A
    Pediatr Diabetes; 2004; 5 Suppl 2():88-93. PubMed ID: 15601379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro (re)programming of human bone marrow stromal cells toward insulin-producing phenotypes.
    Limbert C; Seufert J
    Pediatr Diabetes; 2009 Sep; 10(6):413-9. PubMed ID: 19627549
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.